Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy M Fan

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Biorxiv : the Preprint Server for Biology|January 4, 2022
Engineered High-Affinity ACE2 Peptide Mitigates ARDS and Death Induced by Multiple SARS-CoV-2 VariantsLianghui Zhang, Soumajit Dutta, Shiqin Xiong, et al.
BMC Cancer|October 31, 2024
B7-H3 is widely expressed in soft tissue sarcomasMeghan M Lynch, Rusul Al-Marayaty, Farres Obeidin, et al.
British Journal of Cancer|December 5, 2022
Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignanciesOana C Danciu, Matthias Holdhoff, Richard A Peterson, et al.
Neuro-Oncology Advances|August 9, 2023
Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomasMatthias Holdhoff, M Kelly Nicholas, Richard A Peterson, et al.
Neuro-Oncology|July 3, 2021
Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patientsEmily J Tonogai, Shan Huang, Rachel C Botham, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2014
Investigating the optimal size of anticancer nanomedicineLi Tang, Xujuan Yang, Qian Yin, et al.
Journal for Immunotherapy of Cancer|May 31, 2023
Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse modelDiana Rose E Ranoa, Preeti Sharma, Claire P Schane, et al.
Nature Chemical Biology|February 14, 2017
Selective in vivo metabolic cell-labeling-mediated cancer targetingHua Wang, Ruibo Wang, Kaimin Cai, et al.
Molecular Cancer Therapeutics|July 25, 2022
Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing DogsAmy K LeBlanc, Christina N Mazcko, Timothy M Fan, et al.
Nature Chemical Biology|April 25, 2024
Minimizing higher-order aggregation maximizes iron mobilization by small moleculesAndrew D Blake, Jianhua Chao, Anna M SantaMaria, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|January 4, 2022
Engineered High-Affinity ACE2 Peptide Mitigates ARDS and Death Induced by Multiple SARS-CoV-2 VariantsLianghui Zhang, Soumajit Dutta, Shiqin Xiong, et al.
BMC Cancer|October 31, 2024
B7-H3 is widely expressed in soft tissue sarcomasMeghan M Lynch, Rusul Al-Marayaty, Farres Obeidin, et al.
British Journal of Cancer|December 5, 2022
Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignanciesOana C Danciu, Matthias Holdhoff, Richard A Peterson, et al.
Neuro-Oncology Advances|August 9, 2023
Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomasMatthias Holdhoff, M Kelly Nicholas, Richard A Peterson, et al.
Neuro-Oncology|July 3, 2021
Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patientsEmily J Tonogai, Shan Huang, Rachel C Botham, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2014
Investigating the optimal size of anticancer nanomedicineLi Tang, Xujuan Yang, Qian Yin, et al.
Journal for Immunotherapy of Cancer|May 31, 2023
Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse modelDiana Rose E Ranoa, Preeti Sharma, Claire P Schane, et al.
Nature Chemical Biology|February 14, 2017
Selective in vivo metabolic cell-labeling-mediated cancer targetingHua Wang, Ruibo Wang, Kaimin Cai, et al.
Molecular Cancer Therapeutics|July 25, 2022
Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing DogsAmy K LeBlanc, Christina N Mazcko, Timothy M Fan, et al.
Nature Chemical Biology|April 25, 2024
Minimizing higher-order aggregation maximizes iron mobilization by small moleculesAndrew D Blake, Jianhua Chao, Anna M SantaMaria, et al.
Pageof 12